Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type ...

The Global Digital Therapeutics Market is valued at USD 7.95 Billion in 2024 and is projected to reach a value of USD 75.71 ...

The digital therapeutics (DTx) market is experiencing significant growth with a projected CAGR of 25-27% over the next few ...

Download our guide to the digital therapeutics landscape, key providers, and market trends. Discover how digital health solutions can enhance pharmaceutical outcomes.

Hyfe’s CEO Tamsin Chislett spoke with Pharmaceutical Executive about this new technology, along with how digital therapeutics ...

It was a mixed day for Daewoong Pharmaceutical Co. Ltd., which disclosed separately on March 28 both the termination of a $336 million licensing deal with CS Pharmaceuticals Ltd. and upbeat plans to ...

Pfizer was also developing a twice-daily formulation of the drug, which showed promising weight loss, but was plagued by ...

The V12-powered DB11 AMR will soon get a V8-engined successor, although it's not clear if the hotter DB12 will also bear the AMR suffix ...

Currently, DTX is worth just $0.18, an 800% rise from its starting value of $0.02. This altcoin price will surge by another 100% to $0.36 after a Tier-1 CEX lists it soon. In other words, anyone ...

Learn more about whether Envista Holdings Corporation or Penumbra, Inc. is a better investment based on AAII's A+ Investor ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...